[Cerebral infarction]
- PMID: 17087294
[Cerebral infarction]
Abstract
Diabetes mellitus is the second major risk factor for ischemic stroke. Recent increase in atherothrombotic stroke appears to be related with recent increasing of diabetes. Diabetes is, however, a risk factor not only for atherothrombotic stroke but also for lacunar stroke because there is no difference in prevalence of diabetes between atherothrombotic and lacunar strokes. Diabetes can be a risk factor for cardioembolic stroke as well because the major cause of cardioembolic stroke is atrial fibrillation, and diabetes is a risk factor for stroke in patients with atrial fibrillation. Acute ischemic stroke should be classified into above three subtypes according to the brain and artery imaging as well as cardiac sources of embolism. In hyper-acute patients within 3 hours of onset and without early ischemic signs on CT or ischemic lesions less than one third of the hemisphere on magnetic resonance diffusion-weighted imaging, thrombolytic therapy with alteplase is indicated. In acute stroke patients later than 3 hours of onset, argatroban, heparin, and ozagrel are indicated for atherothrombotic, cardioembolic, and lacunar stroke, respectively. For stroke prevention, total management is required by simultaneous treatments for all risk factors existed. In secondary prevention for stroke, in addition to the more strict control of risk factors antithrombotic therapy is required, that is, antiplatelet therapy is indicated for non-cardioembolic stroke, and anticoagulant therapy is indicated for cardioembolic stroke.
Similar articles
-
[Antithrombotic therapy in cerebral infarction].Rinsho Shinkeigaku. 2000 Dec;40(12):1251-3. Rinsho Shinkeigaku. 2000. PMID: 11464470 Review. Japanese.
-
[Differential diagnosis of acute ischemic stroke and management on the basis of acute ischemic stroke subtype].Rinsho Shinkeigaku. 2004 Nov;44(11):914-7. Rinsho Shinkeigaku. 2004. PMID: 15651330 Review. Japanese.
-
Atherothrombotic ischemic stroke in patients with atrial fibrillation.Clin Neurol Neurosurg. 2007 Jul;109(6):485-90. doi: 10.1016/j.clineuro.2007.03.009. Epub 2007 Apr 30. Clin Neurol Neurosurg. 2007. PMID: 17467891
-
[Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment].Rev Neurol. 2004 Mar 1-15;38(5):401-5. Rev Neurol. 2004. PMID: 15029514 Spanish.
-
[Diagnosis and treatment of cerebral infarction].Nihon Rinsho. 2010 May;68(5):920-5. Nihon Rinsho. 2010. PMID: 20446593 Japanese.
Cited by
-
Study on Circulating lncRNA Expression Profile in Patients with Cerebral Infarction.Dis Markers. 2022 May 9;2022:3042105. doi: 10.1155/2022/3042105. eCollection 2022. Dis Markers. 2022. Retraction in: Dis Markers. 2023 Aug 2;2023:9895860. doi: 10.1155/2023/9895860. PMID: 35585938 Free PMC article. Retracted.
-
Association between genetic polymorphisms of interleukins and cerebral infarction risk: a meta-analysis.Biosci Rep. 2016 Nov 3;36(6):e00404. doi: 10.1042/BSR20160226. Print 2016 Dec. Biosci Rep. 2016. PMID: 27679860 Free PMC article.
-
Impact of hemoglobin glycation index on prognosis in critical patients with acute ischemic stroke: A retrospective cohort study using MIMIC-IV 2.2 database.Sci Rep. 2025 Jul 2;15(1):23095. doi: 10.1038/s41598-025-07833-6. Sci Rep. 2025. PMID: 40595190 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical